Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Sep 20, 2012 (14 years ago)

Nutropin AQ NuSpin 20

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).

Cause type: Packaging defect

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.

What was recalled

Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genentech, South San Francisco, CA 94080, NDC#50242-0076-01

Affected NDC 50242-0076-01

Compare with the code on your package — it is the most precise check available.

Drug: Somatropin

Recalling firm
Genentech Inc
NDC code
50242-0076-01
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-087-2013 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Somatropin recalls

See all
Class II · Moderate risk

ZOMA-Jet 10 Demonstration Kit

Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Terminated Packaging defect Ferring Pharmaceuticals Inc D-0318-2021
Class II · Moderate risk

ZOMA-Jet 5 Demonstration Kit

Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Terminated Packaging defect Ferring Pharmaceuticals Inc D-0317-2021
Class II · Moderate risk

Norditropin FlexPro Somatropin

Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step

Terminated Packaging defect Novo Nordisk Inc NDC 0169-7703-21 D-0956-2016
Class II · Moderate risk

Tev-Tropin

Chemical Contamination: TEV-TROPIN [somatropin (rDNA origin) for injection] may contain silicone oil due to leakage of a leaking line during the freeze-drying process.

Terminated Chemical / undeclared Ferring Pharmaceuticals Inc NDC 57844-713-46 D-1385-2014

Other recalls by Genentech Inc

All 2012 recalls
Class II · Moderate risk

Cathflo activase

Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.

Terminated Sterility / contamination Genentech, Inc. NDC 50242-041-64 D-0509-2024
Class III · Low risk

Susvimo (ranibizumab injection)

Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it non-functioning.

Terminated Packaging defect Genentech Inc NDC 50242-078-55 D-0025-2023
Class II · Moderate risk

Xolair (omalizumab)

Failed Stability Specifications: Out of Specification results of Polysorbate 20 (PS20) content were detected at the 12 month testing time point.

Terminated Stability / shelf life Genentech Inc D-0650-2021
Class III · Low risk

Evrysdi (risdiplam)

Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with co-packed syringes.

Terminated Packaging defect Genentech Inc D-0357-2021